CC BY-NC-ND 4.0 · Journal of Cardiac Critical Care TSS 2020; 04(01): 20-24
DOI: 10.1055/s-0040-1714151
Review Article

Multiorgan Involvement in COVID-19 and Possible Therapies

Prachee Sathe
1  Department of Critical Care Medicine, Ruby Hall Clinic, Grant Medical Foundation, Pune, Maharashtra, India
,
Vijay Sundar Singh
2  Department of Critical Care Medicine, DY Patil Medical College, Pune, Maharashtra, India
› Author Affiliations
  

Abstract

In late 2019, China reported cases of respiratory illness in humans, which involved a novel Coronavirus SARS-CoV-2 (also known as 2019-nCoV). The World Health Organization (WHO) termed the disease COVID-19 (i.e., Coronavirus disease 2019). Most of the morbidity and mortality from COVID-19 is largely due to acute viral pneumonitis that leads to acute respiratory distress syndrome (ARDS). This article will discuss the clinical features of the multiorgan involvement in COVID-19 as well as the management of patients who become critically ill due to COVID-19.



Publication History

Publication Date:
13 July 2020 (online)

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India